Boston, MA 06/07/2013 (wallstreetpr) – The share prices of Skystar Bio – Pharmaceutical Company (NASDAQ:SKBI) had surged by 20.33 percent to close at $1.48 per share for the last trading session on Thursday. The shares of the company had recorded an intraday high price of $1.87 per share and an intraday low price of $1.28 per share on Thursday.
Skystar Bio – Pharmaceutical Company (NASDAQ:SKBI) functions as a holding company based in China with primary focus on the development and commercialization of veterinary health care and medical care products. In the first quarter financial results for fiscal year 2013, the bio pharmaceutical company reported a decline in revenue of 30 percent year on year to $5.5 million. Further, the net income for Skystar Bio – Pharmaceutical Company (NASDAQ:SKBI) in the first quarter was reported to be $0.7 million or 9 cents per fully diluted share, compared to $1.9 million or 26 cents gain per fully diluted share for the same quarter of previous year.
The shares of Skystar Bio – Pharmaceutical Company (NASDAQ:SKBI) had recorded 52 week high price level of $2.41 per share and 52 week low price level of $1.00 per share. The shares of the company witnessed the trade of 420,127 shares on Thursday, while the average trading volume of Skystar Bio – Pharmaceutical Company (NASDAQ:SKBI) is at just 8,090 shares per day.
Skystar Bio – Pharmaceutical Company (NASDAQ:SKBI) presently holds 7.60 million shares outstanding in the market and the institutional ownership in the veterinary care products retailer is at 4 percent of its holdings.
